PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

Management 105

Management Manufacturing Sales Competition 105

European Pharmaceutical Review

APRIL 28, 2023

The European Commission ’s (EC’s) reform of the EU pharmaceutical legislation published on 26 April 2023, adopted a proposal for a new Directive and a new Regulation. To mitigate this, he strongly recommended “a comprehensive competitiveness check is conducted on the impact of the revised pharmaceutical legislation.”

Pharmaceutical 82

Pharmaceutical Pharma Medicine Competition 82

Pharma Marketing Network

MARCH 23, 2023

As cookies become obsolete, pharma marketers will need to find new ways to reach and engage with consumers. For example, pharma marketers can use email marketing to reach consumers with relevant health and wellness information, or use SMS marketing to send appointment reminders or refill notifications. References: 1. ” Hubspot.

Marketing 52

Marketing Pharma Consulting Competition 52

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. “The industry now regards the current approach, due to end in 2023, as broken.” VPAS tax on top. . VPAS tax on top. .”

Pharma 70

Pharma Government Manufacturing Competition 70

Star OUTiCO

NOVEMBER 30, 2022

January is one of the busiest recruiting times, so starting your hunt this month could mean lower competition and possibly improve your odds of securing your dream job. Reassess ahead of 2023. Some larger pharma clients are really going above and beyond to try and dangle that golden carrot Sarah Whitby, Pharma Outsourcing Lead.

Recruitment 98

Recruitment Pharma Leads Competition 98

pharmaphorum

SEPTEMBER 5, 2022

The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director. ” The action will only be heard if the Competition Appeal Tribunal (CAT) upholds the CMA’s findings against Alliance, it added. .”

Pharma 57

Pharma Competition Management Marketing 57

Clarivate

DECEMBER 19, 2022

For 2023 Medicare Advantage open enrollment, the United States’ largest retailer will begin a 10-year partnership with the nation’s largest insurer. The partnership dovetails with Walmart Health’s plans for 15 new Florida clinics across the Jacksonville, Orlando and Tampa markets by the end of 2023. MA national enrollment.

Competition 52

Competition Retail Insurance Marketing 52

European Pharmaceutical Review

MARCH 7, 2023

The Pistoia Alliance has launched its Pharma Innovation Council. The Council will explore common challenges develop ideas for new pre-competitive projects aligned with the Alliance’s strategic themes, including Emerging Sciences and Technology and Improving the Efficiency and Effectiveness of R&D.

Pharma 64

Pharma Consulting Leads Competition 64

Pharmaceutical Technology

MAY 16, 2023

More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. This resulted in a 3.4% decline in total aggregate market capitalisation from $3.61 trillion in Q4 2022 to $3.49

Marketing 52

Marketing Sales Pharma Leads 52

Clarivate

JANUARY 23, 2024

The just-published 2023 Factbook indicates an industry that is becoming more nimble and efficient in its R&D over the long haul. Figure 1: Number of NME launches from 2013 to 2022 Analyses from the 2023 R&D Factbook also indicate that the number of late phase terminations has consistently declined in recent years.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

PM360

OCTOBER 13, 2023

For the next 12 to 24 months, the media landscape is set to drastically change and pharma marketers can’t miss this hidden opportunity. billion in 2023 from these fees. Threads on the other hand is the spitting image of brand safety—if pharma developed an industry-centric platform, this would be it. Will streaming evolve?

Media 69

Media Pharma Networking Safety 69

Eversana Intouch

JANUARY 19, 2023

Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. – is changing, and has big implications for the competitive marketplace. Pharma marketers in 2023 need to: Look for blind spots. or technology, too?

Medical 52

Medical Education Competition Marketing 52

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. Are you intrigued to know what technologies will rule the pharma market and how they can benefit your business in 2023? from 2022 to 2030, the pharma industry will reach USD 9,241.34 billion during 2020-2024.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

APRIL 7, 2023

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. pharma sales in 2020) and the size of 340B discounts (25-50%), companies may see significantly reduced revenues for important products.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

World of DTC Marketing

MARCH 17, 2021

The rapid rollout of Covid-19 vaccines has made household names of Pfizer and AstraZeneca, and the whole industry is winning praise for co-operation” However, the bump in reputation will be short-lived because companies need to earn the public’s trust every day, and pharma is already damaging their perception with people.

Pharma 186

Pharma Competition Prescription Doctors 186

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 105

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 105

Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. Pharma is placing bigger bets on a smaller number of therapeutics and technology platforms.

Pharma 52

Pharma Biopharma Medicine Competition 52

eMediWrite

AUGUST 30, 2023

Pharma MSMEs might not have the negotiation leverage or other options necessary to properly handle late payments. Challenges posed by payments that are late for pharma MSMEs For pharma MSMEs, late payments present formidable obstacles. The solution to the issue of delayed payments is collaboration.

Pharma 52

Pharma Government Electronics Pharmaceutical 52

Star OUTiCO

DECEMBER 1, 2023

This time of year is particularly competitive for recruitment within pharma, medtech, and biotech, so setting goals and staying organised will help you immeasurably. ‘ This time of year is particularly competitive for recruitment within pharma, medtech, and biotech, so setting goals and staying organised will help you immeasurably. ‘

Pharma 52

Pharma Recruitment Networking Consulting 52

European Pharmaceutical Review

NOVEMBER 30, 2023

Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.

Manufacturing 73

Manufacturing Recruitment Medicine Biopharma 73

Pharma Marketing Network

DECEMBER 17, 2021

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. HCP Engagement and Pharma Salesforces.

Pharma 105

Pharma Marketing Engineering Digital Media 105

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Competition 95

Competition Consulting Marketing Pharma 95

European Pharmaceutical Review

NOVEMBER 8, 2022

Under two other pending bills – House of Representatives Bill 2883, titled Stop Stalling Access to Affordable Medications, and Senate Bill 1425, titled Stop STALLING 4 Act – it would be unfair competition to submit an “objectively baseless petition” to the FDA in an attempt to interfere with a competitor’s application to market a drug.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

pharmaphorum

JULY 21, 2022

The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward. billion ($33.2

Sales 109

Sales Pharma Competition Management 109

PM360

DECEMBER 20, 2023

With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This allows for a complementary portfolio fit without the kind of competitive overlap that comes under regulatory scrutiny from the FTC.

Biopharma 111

Biopharma Pharma Marketing Management 111

Impetus Digital

MARCH 15, 2024

Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). There are currently more than 2,000 oncology products under development.

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

Pharmaceutical Technology

FEBRUARY 8, 2023

trillion over the past year, according to GlobalData’s Pharma Intelligence Center Companies Database. billion for 2022, according to GlobalData’s Drugs Database Pharma Intelligence Center. for 2022 according to GlobalData’s Drugs Database Pharma Intelligence Center analyst consensus. trillion to $3.61 and 31.6%, respectively.

Marketing 78

Marketing Biopharma Sales Pharma 78

Pharmaceutical Technology

DECEMBER 20, 2022

trillion in Q3, according to GlobalData’s Pharma Intelligence Center Companies Database. The growing competition from generic drugs presents challenges for the top 20 players placing pressure on drug prices. The top 20 global biopharmaceutical companies exhibited a downward trend in aggregate market capitalisation by 9.1%

Biopharma 52

Biopharma Marketing Competition Sales 52

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year.

Competition 59

Competition Marketing FDA Physicians 59

PM360

NOVEMBER 13, 2023

Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. PRECISIONxtract 2023 Annual HCP Survey. Edelman, “2023 Trust Barometer Report,” accessed October 26, 2023. References: 1.

Media 52

Media Prescription Healthcare Provider Patients 52

Spotio

FEBRUARY 23, 2023

A decade ago, pharma reps could easily book in-person meetings with doctors, build lasting relationships, and crush their sales quotas. Physicians are harder to get hold of in 2023. We have yet to talk about the increased level of competition that modern reps have to deal with. Pharmaceutical sales have changed. These days?

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Pharma sales reps Pharmaceutical 52

pharmaphorum

SEPTEMBER 7, 2022

Gilead Sciences’ Kite Pharma unit has carved out a niche for its CD19-targeted CAR-T therapy Tecartus in acute lymphoblastic leukaemia (ALL) in Europe, free of direct competition from arch-rival Novartis. However, results from that are not due until 2023.

Sales 92

Sales Patients Competition Pharma 92

Veeva

JULY 13, 2023

In today’s competitive pharmaceutical industry, field teams need to be agile, dynamic and efficient to meet the evolving needs of healthcare professionals and patients. For pharma companies, optimizing resource allocation in their field teams is crucial to maximize productivity and return on investment.

Competition 52

Competition CRM Healthcare Provider Pharma 52

Star OUTiCO

DECEMBER 11, 2023

Being part of Uniphar, we’ve got so many resources and experts across all areas of pharma and medtech, and specialisms under that. 2023 has been extremely challenging across all sectors and all areas. Candidates really need to set themselves apart from their competition. I like doing anything outdoorsy!

Recruitment 52

Recruitment Consulting Competition Specialization 52

Clarivate

APRIL 18, 2024

Amazon’s big splash happened in February 2023 when it purchased the national primary-care practice One Medical for $3.9 Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare.

Retail 52

Retail Healthcare Healthcare Physicians 52

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

pharmaphorum

AUGUST 2, 2022

Now, Roche has an opportunity to add ease of administration to the competitive profile of Tecentriq, reducing the time patients have to spend in clinics and potentially reducing the cost of treatment. Results from a trial in first-line NSCLC are due in early 2023.

Marketing 98

Marketing Competition Patients FDA 98